Breast Lesion Localization Methods Market Growth during 2021-2030 | Rise in Demand, Opportunities, Type, Future Analysis

The Global Breast Lesion Localization Methods Market size is estimated to be USD 745.4 million in 2019 and is predicted to reach USD 2831.7 million by 2030 with a CAGR of 12.9% from 2020-2030.

Breast lesion is an injury or an abnormal change in the breast tissue. These lesions can be malignant or benign and must be removed or treated immediately. This in turn, requires accurate localization method, which is required to ensure correct and adequate removal of the lesions and to minimize the degree of cosmetic disfigurement. Breast lesion localization method is a pre-surgical procedure where localization devices such as, magnetic tracer, radioisotopes, wires are used to insert into the cancer detected site to localize a non-palpable lesion at the time of surgical excision.

Over the past few decades, mammograms and other screening and diagnostic breast imaging methods have led to the earlier detection of breast cancer as well as an increase in the diagnosis of lesions requiring excisional biopsy. To ensure the accurate removal of the target tissue the removal of these small breast lesions requires a localization device. With earlier detection of breast lesions, localization procedures have become necessary in up to 50% of all lumpectomy and surgical biopsy procedures to ensure accurate removal of the target lesion. Moreover, technological advancement in breast lesion localization methods such as magnetic tracers offer significant growth opportunities for the players in this market.

Access Full Description of this report at:-

https://www.nextmsc.com/report/breast-lesion-localization-methods-market

Top Companies: Cook Medical, C.R. Bard, Argon Medical Devices, GE Healthcare, SOMATEX Medical Technologies, Ranfac Corporation, Biomedical, Laurane Medical, NuclearLab S.R.L., and Matek Medical and others.

Market Dynamics and Trends:

Growing incidence and prevalence of breast cancer is the major driver for breast lesion location methods. The Breast Cancer Organization estimated that in 2018, 266,120 new cases of invasive and 63,960 cases of non-invasive breast cancer would be diagnosed. Additionally, changing reimbursement policies across the globe for breast cancer diagnostics, biopsy, and other procedures, technological advancements and increasing demand for better healthcare infrastructure and facilities are some other factors driving the growth of breast lesion localization methods market. However, uncertainty in regulatory approval procedures due to risk associated with breast lesion localization devices are expected to hinder the market growth during the forecast period.

Major players in the breast lesion localization market mainly focus on product development, enhancements and launches as its primary growth strategy. In 2017, Faxitron received FDA approval to introduce its LOCalizer radio frequency identification (RFID) lesion localization system. This product is intended for tagging and subsequently honing in on breast lesions during surgeries. The company also received distribution rights for Health Beacons’ RFID breast lesion localization system. Such developments enable the players to increase their customer base, gain significant market share and achieve competitive edge in the breast lesion localization methods market.

Request sample copy of this report at:-

https://www.nextmsc.com/Breast-Lesion-Localization-Methods-Market/request-sample

Market Segmentations and Scope of the Study:

The breast lesion localization methods market share is analysed on the basis of type, end user and geography. On the basis of type the market is segmented into wire guided localization, magnetic tracers, radioisotope localization and electromagnetic reflectors. The end user segment covers the breast lesion localization methods market for diagnostic centres, hospitals, ambulatory surgical centers, and oncology centers. The geographical segment of the advanced ceramics market covers North America, Europe, Asia Pacific, and Rest of the World.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.